Liminatus Pharma, Inc. Class A Common Stock is a publicly traded company trading on NASDAQ, led by CEO Chris Kim, with a market cap of $7.4M.
Based on Q1 2026 filing
Common questions about Liminatus Pharma, Inc. Class A Common Stock
Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a market capitalization of $7.4M and trades on NASDAQ.